Literature DB >> 20805202

Governments, pay for smoking cessation.

Erika D Penz, Braden J Manns, Paul C Hébert, Matthew B Stanbrook.   

Abstract

Mesh：

Year:  2010        PMID： 20805202      PMCID： PMC3001517          DOI： 10.1503/cmaj.101140

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.

Authors:  N F Woolacott; L Jones; C A Forbes; L C Mather; A J Sowden; F J Song; J P Raftery; P N Aveyard; C J Hyde; P M Barton
Journal:  Health Technol Assess       Date:  2002       Impact factor: 4.014

Review 2.  Is tobacco use a disease?

Authors:  Katherine Frohlich
Journal:  CMAJ       Date:  2008-10-21       Impact factor: 8.262

3.  Mortality in relation to smoking: 40 years' observations on male British doctors.

Authors:  R Doll; R Peto; K Wheatley; R Gray; I Sutherland
Journal:  BMJ       Date:  1994-10-08

Review 4.  Healthcare financing systems for increasing the use of tobacco dependence treatment.

Authors:  Ayalu A Reda; Janneke Kaper; Hurmuz Fikrelter; Johan L Severens; Constant Paul van Schayck
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

5.  Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.

Authors:  K Fiscella; P Franks
Journal:  JAMA       Date:  1996-04-24       Impact factor: 56.272
  5 in total
  5 in total

1.  Medical education needed for smoking cessation.

Authors:  Joan M Brewster
Journal:  CMAJ       Date:  2010-11-09       Impact factor: 8.262

2.  Governments, pay for smoking cessation.

Authors:  Norman J Temple
Journal:  CMAJ       Date:  2010-11-09       Impact factor: 8.262

3.  Bravo and beware.

Authors:  Frederic Bass
Journal:  CMAJ       Date:  2010-10-19       Impact factor: 8.262

4.  Public Health Policy in Support of Insurance Coverage for Smoking Cessation Treatments.

Authors:  Robert Schwartz; Farzana Haji; Alexey Babayan; Christopher Longo; Roberta Ferrence
Journal:  Healthc Policy       Date:  2017-05

5.  A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).

Authors:  Peter Selby; Gerald Brosky; Paul Oh; Vincent Raymond; Carmen Arteaga; Suzanne Ranger
Journal:  BMC Public Health       Date:  2014-05-07       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.